ASPEN PHARMACARE HOLDINGS LIMITED - Renewal of Cautionary Announcement API Business

Renewal of Cautionary Announcement – API Business

ASPEN PHARMACARE HOLDINGS LIMITED
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries (collectively “Aspen” or “the Group”)



RENEWAL OF CAUTIONARY ANNOUNCEMENT – API BUSINESS

Shareholders are referred to the cautionary announcement released by Aspen on 9 September 2021 in
which shareholders were advised that Aspen had received two unsolicited offers for its active
pharmaceutical ingredient business (“API Business”)(1). This announcement also confirmed that Aspen had
decided to embark on a structured process to facilitate offers for all or parts of its API Business from those
parties that submitted the unsolicited offers and other selected interested parties.

Shareholders are advised that this structured process remains ongoing and may have a material effect on
the price of Aspen’s securities if successfully concluded and accordingly shareholders are advised to
continue exercising caution when dealing in Aspen’s securities.

Footnote:
(1) Comprising the Chemicals and Biochem segments of Aspen’s Manufacturing operations, situated in the Netherlands,
    South Africa and the United States.

Durban
21 October 2021

Sponsor
Investec Bank Limited






Date: 21-10-2021 05:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.